Analysis on postoperative efficacy of radical hepatectomy for patients with non-HBV/HCV hepatocellular carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 8, 2015, Pages 3479-3483

  Zhang, Zhi Ming ^a   Zhang, Yu Mei ^a   Yao, Feng ^a   Yi, Ping ^a   Huang, Shang ^a   Liu, Jian Yong ^a   Xiang, Bang De ^a   Yuan, Wei Ping ^a   Li, Le Qun ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Non HBV HCV infection

Indexed keywords

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHINA; CHRONIC HEPATITIS C; COMPLICATION; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS B; HUMAN; LIVER NEOPLASMS; LIVER RESECTION; MALE; MIDDLE AGED; MIXED INFECTION; POSTOPERATIVE PERIOD; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE; YOUNG ADULT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHINA; COINFECTION; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84929012210     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.8.3479     Document Type: Article

References (22)

1. Bruix J, Boix L, Sala M, et al (2004). Focus on Hepatocellular carcinoma. Cancer Cell, 5, 215-9.
2. Bruix J, Sala M, Llovet JM (2004). Chemoembolization for hepatocellular carcinoma. Gastroenterol, 127, S179-88.
3. Calle EE, Rodriguez C, Walker-Thurmond K, et al (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 348, 1625-38.
4. Carr BI, Guerra V, Steel JL, et al (2015). A Comparison of Patients With Hepatitis B-or Hepatitis C-Based Advanced-Stage Hepatocellular Carcinoma. Semin Oncol, 42, 309-315.
5. Dai XZ, Yin HT, Sun LF, et al (2013). Potential therapeutic efficacy of curcumin in liver cancer. Asian Pac J Cancer Prev, 14, 3855-9.
6. Fattovich G, Stroffolini T, Zagni I, et al (2004). Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterol, 127, S35-50.
7. Graf D, Vallböhmer D, Knoefel WT, et al (2014). Multimodal treatment of hepatocellular carcinoma. Eur J Intern Med, 25, 430-7.
8. Jeng JE, Tsai MF, Tsai HR, et al (2014). Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis inhepatocellular carcinoma related to betel quid chewing. Asian Pac J Cancer Prev, 15, 637-42.
9. Kar P (2014). Risk factors for hepatocellular carcinoma in India. J Clin Exp Hepatol, 4, S34-42.
10. Kim MN, Han KH, Ahn SH (2015). Prevention of Hepatocellular Carcinoma: Beyond Hepatitis B Vaccination. Semin Oncol, 42, 316-28.
11. Li X, Zhong X, Chen ZH, et al (2014). Hepatitis B virus DNA negativity acts as a favorable prognostic factor inhepatocellular carcinoma patients. Asian Pac J Cancer Prev, 15, 9635-41.
12. Liu Y, Xie L, Zhao J, Huang X, et al (2015). Association between catalase gene polymorphisms and risk of chronic hepatitis B, hepatitis B virus-related liver cirrhosis and hepatocellular carcinoma in guangxi population: a case-control study. Medicine, 94, e702.
13. Maida M, Orlando E, Cammà C, et al (2014). Staging systems of hepatocellular carcinoma: a review of literature. World J Gastroenterol, 20, 4141-50.
14. Morise Z, Kawabe N, Tomishige H, et al (2014). Recent advances in the surgical treatment of hepatocellular carcinoma. World J Gastroenterol, 20, 14381-92.
15. Norsa'adah B, Nurhazalini-Zayani CG (2013). Epidemiology and survival of hepatocellular carcinoma in north-east Peninsular Malaysia. Asian Pac J Cancer Prev, 14, 6955-9.
16. Oyunsuren T, Sanduijav R, Davaadorj D, et al (2006). Hepatocellular carcinoma and its early detection by AFP testing in Mongolia. Asian Pac J Cancer Prev, 7, 460-2.
17. Poon RT, Fan ST, Ng IO, et al (2000). Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical. Ann Surg, 231, 544-51.
18. Ramesh H (2014). Resection for hepatocellular carcinoma. J Clin Exp Hepatol, 4, S90-6.
19. Yamamoto Y, Ikoma H, Morimura R, et al (2015). Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy. World J Gastroenterol, 21, 1207-15.
20. Xu C, Lv PH, Huang XE, et al (2014). Safety and efficacy of sequential transcatheter arterial chemoembolization and portal vein embolization prior to major hepatectomy for patients with HCC. Asian Pac J Cancer Prev, 15, 703-6.
21. Yang X, Gao JY, Wang J, et al (2015). The impact of anti-HBV treatment on the occurrence and Recurrence ofhepatocellular carcinoma: focus on Asian studies. Discov Med, 19, 89-99.
22. Zhu WJ, Huang CY, Li C, et al (2013). Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting Milan criteria after curative resection. Asian Pac J Cancer Prev, 14, 7101-6.